The Financial Times is hosting a high‑profile discussion titled “Unlocking Health Through the Human Exposome,” where three senior members of the Global Exposome Forum from North America and Europe will brief the scientific community on milestones achieved since the initiative’s launch in Washington, D.C., May 2025.
Attendees at the AAAS Annual Meeting will learn why many experts view the exposome—a comprehensive inventory of all environmental exposures over a lifetime—as one of the most promising avenues for improving public health today. The conversation will revolve around three pillars: the transformative power of exposomics, a roadmap for a truly worldwide research network, and concrete steps for tackling scientific and regulatory hurdles.
Panel chair Professor Thomas Hartung (Johns Hopkins Bloomberg School of Public Health) stressed the ambition behind the effort: “We aim to create ripples that become waves across the health landscape. In the past nine months our working groups have built momentum, secured governmental backing, and laid the groundwork for collaborative projects that span continents.” He hinted that three new partnership announcements—linking national agencies, global scientific bodies, and large membership organizations—will be revealed during the session.
The discussion is slated for Room West 105 at the Phoenix Convention Center, 10:00 – 11:00 AM MST on Saturday, 14 February 2026. Access is limited to credentialed press covering the AAAS meeting, but scholars and policy‑makers interested in large‑scale health initiatives are strongly encouraged to attend.
The Human Exposome Initiative: A New Frontier for Medicine
While the Human Genome Project decoded the blueprint of life, it accounted for only a fraction of disease risk—roughly 10‑20 %. In contrast, cumulative biological, chemical, and environmental exposures are believed to explain up to 80 % of health outcomes. The Human Exposome Initiative seeks to fill that gap by systematically cataloguing these exposures and linking them to disease patterns.
Regional chapters and specialized working groups are now accelerating exposomics research by blending artificial intelligence, high‑resolution sensors, metabolomics, and large‑scale data analytics. These interdisciplinary teams are not only publishing findings but also translating insights into public‑policy recommendations that benefit whole populations.
The project deliberately aligns with existing international research agendas, while remaining adaptable to emerging technologies. Organizers stress that embedding robust scientific guidance into policy—especially regarding novel and sometimes contentious tools—is essential for long‑term success. A bottom‑up strategy that engages citizens alongside elected officials is the cornerstone of this effort.
Pan‑African Exposome Collaboration Takes Shape
On 1 December 2025, Pretoria hosted a summit convened by Science Forum South Africa and the World Conference of Science Journalists, under the auspices of the Science Diplomacy Capital for Africa (SDCfA). The gathering evaluated the feasibility of a continent‑wide exposome network and briefed senior officials from the Department of Science, Technology and Innovation.
Outcome: Pan‑African experts will now participate directly in Global Exposome Forum working groups and attend thematic meetings worldwide. Early work will focus on harmonizing health‑data reporting systems—a priority identified during the summit. A follow‑up workshop is planned for December 2026, marking one year since the Pretoria meeting, with SDCfA offering to host the inaugural African exposome hub.
Science Advice, Policy Bridges, and New Partnerships
Professor Rémi Quirion, president of the International Network for Governmental Science Advice (INGSA), has championed exposomics within global advisory circles. INGSA hosted a policy‑focused panel at the May 2025 Washington, D.C., meeting, featuring leaders from UNESCO, WHO, and the African Academy of Sciences.
Since then, INGSA has maintained a dialogue with the Global Exposome Forum on integrating “exposomethics” into regulatory frameworks. A high‑level session is slated for 29 April 2026 at the Global Exposome Summit in Sitges, Spain, and a formal collaboration between INGSA’s 10 000‑member network and the Forum is in the works.
In December 2025, the Forum also announced a joint venture with the Human Cell Atlas and UNESCO, launching a series of virtual town halls that explore single‑cell analysis, genomics, exposomics, and policy. UNESCO will host a follow‑up meeting in Paris on 3 March 2026, paving the way for a Memorandum of Understanding that cements long‑term cooperation.
Regional Momentum and the Upcoming Global Summit
New chapters are emerging across Latin America, the Caribbean, and Southeast Asia, while Europe is preparing the Global Exposome Summit in Sitges (27‑29 April 2026). Registration is already surpassing expectations, and the agenda promises insights from health scientists, AI innovators, supercomputing experts, and forward‑thinking policy architects.
Working Groups Powering Digital Collaboration
At the heart of the Forum’s model are member‑led working groups that tackle pressing scientific and regulatory questions. These groups, comprising representatives from industry, academia, government, and civil society, collaborate on a dedicated digital platform that streamlines communication, document exchange, and coordinated action across borders.
The structure reflects a grassroots philosophy while enabling large‑scale coordination, ensuring that research outputs quickly translate into actionable health policies.
From Blueprint to Reality
Collectively, these developments mark a transition from vision to implementation. By weaving together public and private partnerships, fostering international cooperation, and sharing research infrastructure, the Global Exposome Forum is positioning exposomics as a transformative driver for disease prevention, precision medicine, and sustainable health policy worldwide.